X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4640) 4640
Publication (415) 415
Book Review (29) 29
Dissertation (5) 5
Book Chapter (4) 4
Paper (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3077) 3077
animals (2152) 2152
index medicus (1994) 1994
female (1644) 1644
male (1565) 1565
tissue inhibitor of metalloproteinase-2 - metabolism (1531) 1531
matrix metalloproteinase 2 - metabolism (1465) 1465
expression (1237) 1237
matrix metalloproteinases (1178) 1178
tissue inhibitor (1067) 1067
matrix metalloproteinase 9 - metabolism (899) 899
tissue inhibitor of metalloproteinase-1 - metabolism (877) 877
mice (868) 868
middle aged (820) 820
tissue inhibitor of metalloproteinase-2 - genetics (780) 780
rats (763) 763
cells, cultured (698) 698
adult (677) 677
oncology (649) 649
cell biology (636) 636
immunohistochemistry (636) 636
matrix metalloproteinase 2 - genetics (599) 599
matrix metalloproteinase (592) 592
biochemistry & molecular biology (588) 588
aged (578) 578
gene expression (577) 577
activation (568) 568
rna, messenger - metabolism (510) 510
extracellular-matrix (509) 509
iv collagenase (492) 492
metastasis (483) 483
metalloendopeptidases - metabolism (472) 472
matrix metalloproteinases - metabolism (462) 462
cancer (459) 459
extracellular matrix (457) 457
tissue inhibitor of metalloproteinase-1 - genetics (451) 451
proteins (449) 449
research article (445) 445
research (438) 438
collagen (436) 436
cell line, tumor (413) 413
invasion (401) 401
cells (394) 394
in-vitro (394) 394
medicine (391) 391
blotting, western (386) 386
reverse transcriptase polymerase chain reaction (375) 375
gene-expression (371) 371
matrix metalloproteinase 9 - genetics (366) 366
tissue inhibitors (364) 364
gelatinases - metabolism (363) 363
angiogenesis (352) 352
analysis (345) 345
extracellular matrix - metabolism (345) 345
timp-2 (345) 345
tissue inhibitor of metalloproteinase-2 (341) 341
neoplasm invasiveness (334) 334
inflammation (332) 332
apoptosis (325) 325
tissue inhibitor of metalloproteinase-2 - biosynthesis (306) 306
enzyme activation (301) 301
fibrosis (299) 299
physiological aspects (297) 297
rats, sprague-dawley (296) 296
matrix metalloproteinase inhibitors (295) 295
matrix metalloproteinase-2 (295) 295
collagen - metabolism (293) 293
fibroblasts (292) 292
rna, messenger - genetics (292) 292
multidisciplinary sciences (291) 291
pathology (291) 291
matrix metalloproteinase 2 (283) 283
physiology (282) 282
medicine, research & experimental (279) 279
tumor cells, cultured (279) 279
science (276) 276
time factors (276) 276
tissue inhibitor of metalloproteinases - metabolism (274) 274
mmp-2 (273) 273
disease models, animal (271) 271
metalloproteinase (271) 271
rodents (271) 271
tissue inhibitor of metalloproteinases (269) 269
signal transduction (266) 266
metalloproteinases (265) 265
matrix metalloproteinases, membrane-associated (256) 256
prognosis (248) 248
cell line (245) 245
up-regulation (244) 244
enzyme-linked immunosorbent assay (242) 242
matrix-metalloproteinase-9 (236) 236
health aspects (232) 232
enzymes (230) 230
gelatinase-a (229) 229
matrix metalloproteinase 2 - biosynthesis (229) 229
biology (227) 227
aged, 80 and over (223) 223
article (221) 221
surgery (221) 221
mice, inbred c57bl (210) 210
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4502) 4502
Chinese (108) 108
Russian (17) 17
Polish (7) 7
Japanese (5) 5
French (2) 2
German (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80883
Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in... 
MIGRATION | INACTIVATION | INVASION | COLORECTAL-CANCER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | TISSUE INHIBITOR | FLAVONOIDS | PROGNOSTIC-SIGNIFICANCE | NF-KAPPA-B | CARCINOMA | Transcription, Genetic - drug effects | Protein Binding - genetics | Nitriles - pharmacology | DNA, Neoplasm - metabolism | Humans | Cell Survival - genetics | Extracellular Signal-Regulated MAP Kinases - metabolism | RNA, Messenger - metabolism | Transcription Factor AP-1 - metabolism | Cell Movement - genetics | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Protein Binding - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Mouth Neoplasms - enzymology | Cell Survival - drug effects | Butadienes - pharmacology | Matrix Metalloproteinase 2 - metabolism | Neoplasm Invasiveness | RNA, Messenger - genetics | Signal Transduction - genetics | Down-Regulation - drug effects | Cell Movement - drug effects | Matrix Metalloproteinase 2 - genetics | Matrix Metalloproteinase Inhibitors - pharmacology | Signal Transduction - drug effects | Cell Line, Tumor | Mouth Neoplasms - pathology | Kaempferols - pharmacology | Prevention | Medical research | Care and treatment | Squamous cell carcinoma | RNA | Analysis | Medicine, Experimental | Metastasis | Cardiovascular diseases | Mouth cancer | Cancer | Biotechnology | Food plants | Transcription factors | Tongue | Phosphorylation | Transcription | Oral cancer | Laboratories | Gene regulation | Colorectal cancer | Otolaryngology | Biochemistry | Matrix metalloproteinase | Tissue inhibitor of metalloproteinase 2 | Cancer therapies | Metastases | Angiogenesis | Signal transduction | Cell cycle | Physiology | Metalloproteinase | Food | Kaempferol | Activator protein 1 | Melanoma | Extracellular signal-regulated kinase | c-Jun protein | Plant protection | Breast cancer | Gene expression | Gelatinase A | Studies | Signaling | Bone cancer | Chemotherapy | Flavonoids | Hospitals | Molecular modelling | Cell migration | Apoptosis
Journal Article
Human Reproduction, ISSN 0268-1161, 9/2013, Volume 28, Issue 9, pp. 2407 - 2416
STUDY QUESTION Can biologically active vitamin D3 [1,25(OH)2D3] regulate the expression and activity of matrix metalloproteinases (MMPs) in human uterine... 
TIMP-2 | VDR | fibroids | MMPs | vitamin D3 | MYCOBACTERIUM-TUBERCULOSIS | HEART-FAILURE | TISSUE INHIBITORS | 1-ALPHA,25-DIHYDROXYVITAMIN D-3 | OBSTETRICS & GYNECOLOGY | IN-VITRO | REPRODUCTIVE BIOLOGY | GENE-EXPRESSION | EXTRACELLULAR-MATRIX | COLLAGEN FIBRILS | D-RECEPTOR | NORMAL MYOMETRIUM | Tissue Inhibitor of Metalloproteinase-1 - biosynthesis | Uterine Neoplasms - pathology | Humans | Enzyme Precursors - genetics | Gene Expression Regulation, Neoplastic | Neoplasm Proteins - antagonists & inhibitors | Leiomyoma - metabolism | Neoplasm Proteins - metabolism | RNA, Messenger - metabolism | Receptors, Calcitriol - genetics | Tissue Inhibitor of Metalloproteinase-2 - genetics | Receptors, Calcitriol - biosynthesis | Uterine Neoplasms - enzymology | Antineoplastic Agents - metabolism | Leiomyoma - pathology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Matrix Metalloproteinase 9 - metabolism | Osmolar Concentration | Matrix Metalloproteinase 9 - genetics | Leiomyoma - enzymology | Myometrium - metabolism | Tissue Inhibitor of Metalloproteinase-2 - biosynthesis | Enzyme Precursors - antagonists & inhibitors | Female | Calcitriol - metabolism | Matrix Metalloproteinase 2 - chemistry | Tumor Cells, Cultured | Neoplasm Proteins - genetics | Uterine Neoplasms - metabolism | Myometrium - pathology | Matrix Metalloproteinase 2 - metabolism | Myometrium - enzymology | Receptors, Calcitriol - metabolism | Matrix Metalloproteinase 2 - genetics | Tissue Inhibitor of Metalloproteinase-1 - genetics | Enzyme Precursors - metabolism | Cell Line, Tumor | Matrix Metalloproteinase 9 - chemistry | Original
Journal Article
Journal Article
Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7651, pp. 488 - 492
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 2014, Volume 125, Issue 2, pp. 132 - 141
Many epidemiological studies have strongly suggested an inverse correlation between dietary polyphenol consumption and reduced risks of cardiovascular... 
atherosclerosis | matrix metalloproteinase | tissue inhibitor of matrix metalloproteinase | yellow wine polyphenolic compound | lipid-lowering | Tissue inhibitor of matrix metalloproteinase | Lipid-lowering | Matrix metalloproteinase | Yellow wine polyphenolic compound | Atherosclerosis | TEA POLYPHENOLS | PHENOLIC-COMPOUNDS | DEFICIENT MICE | CORONARY-ARTERY | IN-VIVO | DISEASE | TISSUE INHIBITOR | PHARMACOLOGY & PHARMACY | RED WINE | MEDITERRANEAN DIET POLYPHENOLS | ROSUVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Wine | Plaque, Atherosclerotic - genetics | Polyphenols - pharmacology | Male | Fluorobenzenes - administration & dosage | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Matrix Metalloproteinase 9 - metabolism | Disease Models, Animal | Receptors, LDL - genetics | Hypolipidemic Agents | Matrix Metalloproteinase 2 - metabolism | Pyrimidines - administration & dosage | Mice, Inbred C57BL | Plaque, Atherosclerotic - prevention & control | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Mice, Knockout | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Oryza | Polyphenols - administration & dosage | Sulfonamides - administration & dosage
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article